C29H32O13
588.6 g/mol
APIDanger
Etoposide
CAS33419-42-0EC251-509-1
Category
API
Compound Class
Natural Product
Primary Use
Pharmaceutical Raw Material
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
Relevant lists:California Proposition 65
CAS 33419-42-0
Related Compounds
StrongForm Family
Etoposide phosphate
CAS117091-64-2
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.75
Teniposide
CAS29767-20-2
pharmaceutical raw material
ReferenceSame Category
Trimagnesium dicitrate
CAS3344-18-1
pharmaceutical raw material
ReferenceSame Category
N-Methyl-2-{5-[(pyrrolidine-1-sulfonyl)methyl]-1H-indol-3-yl}ethan-1-amine
CAS334981-12-3
pharmaceutical raw material
ReferenceSame Category
Substance P
CAS33507-63-0
pharmaceutical raw material
ReferenceSame Category
Gonadorelin
CAS33515-09-2
pharmaceutical raw material
Referencestereoisomer of
Cis-Etoposide
CAS100007-56-5
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H350May cause cancer
H340May cause genetic defects
H360May damage fertility or the unborn child
H362May cause harm to breast-fed children
H371May cause damage to organs
H372Causes damage to organs through prolonged or repeated exposure
Regulatory Compliance1
- California Proposition 65USRegulation
Customs Tariff Classification
The international HS code for Etoposide (CAS 33419-42-0) is 2938.90.
HS code (international, 6-digit)
2938.90
EU CN code (8-digit)
2938 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
Identifiers
IUPAC Name
(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
InChIKey
VJJPUSNTGOMMGY-MRVIYFEKSA-N
SMILES
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
Synonyms (68)
- AVOPEF
- EPEG
- EVP
- Etoposide (JP18/USP/INN)
- Etoposide for system suitability, European Pharmacopoeia (EP)
- Etoposide, British Pharmacopoeia (BP)
- Etoposide, European Pharmacopoeia (EP)
- Etoposide, United States Pharmacopeia (USP)
- Etoposido [INN-Spanish]
- Etoposidum [INN-Latin]
- Abiposid;
- Amizide;
- Citodox;
- ETOPOSIDE [MART.]
- Epipodophyllotoxin VP-16213
- Eposide
- Eposin
- Eto GRY
- Etopol
- Etopophos (phosphate salt)
- Etopophos;
- Etoposide (Standard)
- Etoposide (VP16)
- Etoposide - Bio-X trade mark
- Etoposide CRS
- Etoposide Teva
- Etoposido
- Etoposidum
- Etosid
- Exitop;
- Lastet
- Sintopozid
- Teva, Etoposide
- Toposar
- VP 16
- VP 16 (pharmaceutical)
- VP 16-213
- VePESID (TN)
- VePesid
- Vepesid J
- Vepeside;
- Vespid
- Zuyeyidal
- etoposide
- ol-6(8H)-one
- trans-Etoposide